Report: U.S. drug spending on par with South Africa’s GDP
U.S. prescription drug spending grew at a surprisingly modest pace in 2016, notes a new report by QuintilesIMS Institute, though the market still exceeds the annual GDP of South Africa.
U.S. prescription drug spending grew at a surprisingly modest pace in 2016, notes a new report by QuintilesIMS Institute, though the market still exceeds the annual GDP of South Africa.
The QuintilesIMS Institute has released a timely report on the global market for medicines, forecasting a slowdown in drug price increases but overall growth to a massive $1.5 trillion by 2021.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.